Observed arrival · 2026-10-22
AbSynova’s nanobody design-to-bench platform
AbSynova offers nanobody design and screening for research, biotech, and pharma teams, pairing computational candidate design with experimental validation.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Research, biotech, and pharma teams working with nanobodies
- Worth noticing
- Jobs can start from a PDB/mmCIF structure or FASTA sequence, with an optional region specified for binding.
Field notes
The workflow accepts either structural data or a protein sequence, with an optional region of interest, then describes design, binding assessment, and optimization on a compute cluster. Listed deliverables include candidate sequences and complex structures. Its examples range from membrane-protein binding to assay-reagent development and affinity maturation; the page labels them representative and says results vary by target.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
◎NicheUnusually specific use
One card from the complete issue